Congress Highlights
ESGO Congress: A Global Stage for Best Practice & Research in Gynaecological Oncology
A new era of spring congresses has begun for ESGO this year!
The 26th European Congress on Gynaecological Oncology will kick off with an exciting 3-day programme on February 20, 2025.
The upcoming congress will highlight the latest clinical and scientific developments in gynaecological cancers, with more than 50 scientific sessions delivered by renowned international experts focusing on a variety of topics driving research, treatment and care forward.
Don't miss the very best of gynaecological oncology practice and research, latest findings, practical take-home messages and a wealth of knowledge for your daily practice.
Join us in beautiful city of Rome for ESGO 2025, the largest gathering in the field of gynaecological oncology!
ESGO 2025 Programme: More Opportunities to Advance Your Knowledge
-
- Special Live Surgery session
- Exclusive State of the Art sessions in the treatment of gynaecological tumours following the ESGO clinical guidelines
- Debates on hot controversial topics
- Multidisciplinary Tumour Board sessions
- Practice-changing trials in 2024: update on the scientific advances in the results of the latest clinical and surgical trials that are changing daily practice
- Current options for fertility sparing treatment
- Latest advances in chemotherapy, radiotherapy, and immunotherapy
- New emerging pathways and targeted treatments in gynaecological cancers
- Most recent translational research, including biomarkers, liquid biopsies, and antibody-drug conjugates
- Adolescent and young adults cancer treatment
- Treatment of rare tumours and of recurrent diseases
- Artificial intelligence in gynaecological cancers
- Video sessions of the latest surgical and imaging techniques, and tips on how to manage complications
- Oral Presentations of the Best Abstracts
- ENYGO Programme designed for young gynaecological oncologists
- Patient Advocacy Seminar organised by ENGAGe
and much more...
Topics will include the newest aspects in (molecular) diagnostics, surgical, radiotherapeutic and medical concepts, as well as tailored strategies at the time of diagnosis and recurrent disease.
Surgical approaches have been subjected to changes and individualisation, based on both tumour characteristics and patients’ needs.
Improved knowledge about tumour biology and the implementation of new biomarkers has led to new trends of personalised medicine and the selection of patients for individualised treatment.
Interested in finding out more?
The ESGO 2025 interactive online programme, searchable by speaker and topics, will be available soon.